Date: Wednesday, December 19th, 2018
Stock(s) mentioned: BLUE
Source: Motley Fool (https://www.fool.com)
Summary: In recent years, bluebird bio (NASDAQ:BLUE) has excited the medical community with terrific results for experimental therapies. Deep-pocketed biotechs and …
Full article address: https://www.fool.com/investing/2018/12/19/forget-bluebird-bio-amgen-is-a-better-biotech-stoc.aspx
Related News:
$SOLO $CUZ $SPR $BLUE: Report: Exploring Fundamental Drivers Behind Tyson Foods …
$BLUE: bluebird bio Appoints Chip Baird as Chief Financial Officer
$BLUE: Where Will bluebird bio Be in 5 Years?
$BLUE: Here’s What Pushed bluebird bio Stock Down 44.3% in 2018
$SRPT $BLUE $VRTX: 3 Biotech Stocks to Watch in 2019
$BLUE $CI $NOVN.EB $ONCE: Biotech Proposes Paying for Pricey Drugs by Installment
$BLUE: bluebird bio to Present at the 37th Annual JP Morgan Healthcare …
$BLUE: EQUITY ALERT: Rosen Law Firm Announces Investigation of …
$BLUE: Bluebird Bio’s Competitive Advantage Is Underappreciated …
$BLUE: Robbins Arroyo LLP: bluebird bio, Inc. (BLUE) Misled Shareholders …
$BLUE: Glancy Prongay & Murray LLP Announces Investigation on Behalf of …
Latest News:
$SHOP: Forget the Rest of the E-Commerce Upstarts: Shopify Stock Is Still …
$APHA $HAIN: Here’s What Investigators Just Said About Aphria
$XXII: Stull, Stull & Brody Launches Investigation into Possible Breaches of …
$AMZN $NVDA: Tech Stocks This Week: Amazon’s Acquisition, NVIDIA Earnings …
$MCD $SBUX: Why I’m Not Buying the Chipotle Comeback Yet
$PYPL $WU $V: 3 Top Fintech Stocks to Buy in February
$HPP: Hudson Pacific Properties Inc (HPP) CEO Victor Coleman on Q4 …
$CTL: Can CenturyLink Sustain Its New Dividend After Full-Year 2018 …
$BRK-A $BRK-B $DAL $AAL: Warren Buffett Just Sold These Stocks
$RUSHA: Rush Enterprises, Inc. (RUSHA) CEO Rusty Rush on Q4 2018 …
